Posted by The Australian Financial Review on Monday, September 28, 2018 06:02:40The world’s most popular anti-aging skin-care drug is coming to Australia soon.

Dr Kahlil Ahmed, chief executive of the drugmaker, Teva Pharmaceuticals, said the drug was being developed to replace the ageing creams that have caused many patients’ skin to look wrinkled.

“It will be a one-time use product for those who have already used a creamer or serum before.

It won’t cause wrinkles or redness,” he said.”

We’re targeting a much lower level of inflammation than the creams we’re already selling.”

The new drug will be available in Australia for $13.50 a month, or about $150 per year, for a patient’s first year.

It will come in a new cream and a gel and it can be used by women aged between 65 and 90.

But the cream and gel are only available to those in the New South Wales state.

“There’s no cost for the two cream products and the gel is $25 a month.

It will be the same price for a first year of use,” Dr Ahmed said.

The drug, called SULFONIA, has been used for decades by millions of people worldwide.

It has been approved in Europe, Australia and Japan and is available as an ointment, cream or spray.

It is not clear how many people in Australia will be able get the drug.

“At this stage we’re working with doctors to see how they will be approved,” Dr Ahmad said.

In Australia, the average life expectancy is just over 80 years.

“That’s a lot of time that can be wasted, especially when you are dealing with ageing,” Dr Jolyon, who uses the brand name LORAL, said.

Topics:medical-research,drug-use,health,health-administration,drugs-and-substances,healthcare-facilities,diseases-and_disorders,careers,government-and/or-politics,medicine-facility,derbyshire-2600,laboratory-drugs,career,health—industry,melbourne-3000,ausMore stories from New South Welsh

Tags: